ABOUT THE PRODUCT
CTX203 is a lead program advancing toward clinical trials, designed to slow or prevent vision loss in AMD patients.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Character Biosciences
CTX114
Biotechnology
N/A
Character Biosciences
United States (US)